The overexpression of ZYX significantly increased the levels of PCNA, cyclin D1, CDK2 and CDK4 in the HCC cells, indicating that ZYX promotes the proliferation of HCC cells by accelerating G1/S progression [16–19]. Here, CCND1 is linked to hepatocellular carcinoma.